Ausdal Financial Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $393K | Buy |
|
|||||
|
2025
Q2 | $334K | Sell |
|
|||||
|
2025
Q1 | $552K | Buy |
|
|||||
|
2024
Q4 | $415K | Buy |
|
|||||
|
2024
Q3 | $360K | Sell |
|
|||||
|
2024
Q2 | $340K | Sell |
|
|||||
|
2024
Q1 | $478K | Buy |
|
|||||
|
2023
Q4 | $437K | Sell |
|
|||||
|
2023
Q3 | $509K | Sell |
|
|||||
|
2023
Q2 | $615K | Sell |
|
|||||
|
2023
Q1 | $714K | Buy |
|
|||||
|
2022
Q4 | $624K | Buy |
|
|||||
|
2022
Q3 | $596K | Buy |
|
|||||
|
2022
Q2 | $589K | Sell |
|
|||||
|
2022
Q1 | $576K | Buy |
|
|||||
|
2021
Q4 | $379K | Buy |
|
|||||
|
2021
Q3 | $338K | Buy |
|
|||||
|
2021
Q2 | $380K | Sell |
|
|||||
|
2021
Q1 | $362K | Buy |
|
|||||
|
2020
Q4 | $350K | Sell |
|
|||||
|
2020
Q3 | $346K | Buy |
|
|||||
|
2020
Q2 | $261K | Sell |
|
|||||
|
2020
Q1 | $365K | Sell |
|
|||||
|
2019
Q4 | $389K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $339K | Buy |
|
|||||
|
2018
Q2 | $288K | Buy |
|
|||||
|
2018
Q1 | $252K | Sell |
|
|||||
|
2017
Q4 | $301K | Sell |
|
|||||
|
2017
Q3 | $479K | Buy |
|
|||||
|
2017
Q2 | $387K | Buy |
|
|||||
|
2017
Q1 | $361K | Sell |
|
|||||
|
2016
Q4 | $578K | Sell |
|
|||||
|
2016
Q3 | $605K | Buy |
|
|||||
|
2016
Q2 | $511K | Buy |
|
|||||
|
2016
Q1 | $435K | Buy |
|
|||||
|
2015
Q4 | $443K | Buy |
|